Abstract
Viruses depend on host cell resources for replication and access to those resources may be limited to a particular phase of the cell cycle. Thus manipulation of cell cycle is a commonly employed strategy of viruses for achieving a favorable cellular environment. For example, viruses capable of infecting nondividing cells induce S phase in order to activate the host DNA replication machinery and provide the nucleotide triphosphates necessary for viral DNA replication (Flemington in J Virol 75:4475–4481, 2001; Sullivan and Pipas in Microbiol Mol Biol Rev 66:179–202, 2002). Viruses have developed several strategies to subvert the cell cycle by association with cyclin and cyclin-dependent kinase complexes and molecules that regulate their activity. Viruses tend to act on cellular proteins involved in a network of interactions in a way that minimal protein–protein interactions lead to a major effect. The complex and interactive nature of intracellular signaling pathways controlling cell division affords many opportunities for virus manipulation strategies. Taking the maxim “Set a thief to catch a thief” as a counter strategy, however, provides us with the very same virus evasion strategies as “ready-made tools” for the development of novel antivirus therapeutics. The most obvious are attenuated virus vaccines with critical evasion genes deleted. Similarly, vaccines against viruses causing cancer are now being successfully developed. Finally, as viruses have been playing chess with our cell biology and immune responses for millions of years, the study of their evasion strategies will also undoubtedly reveal new control mechanisms and their corresponding cellular intracellular signaling pathways.
Similar content being viewed by others
References
Andersen JS, Lam YW, Leung AK, Ong SE, Lyon CE, Lamond AI, Mann M (2005) Nucleolar proteome dynamics. Nature 433:77–83
Baydoun HH, Pancewicz J, Bai X, Nicot C (2010) HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E–CDK2 interactions and delays cell cycle progression. Mol Cancer 9:302
Bertrand L, Pearson A (2008) The conserved N-terminal domain of herpes simplex virus 1 UL24 protein is sufficient to induce the spatial redistribution of nucleolin. J Gen Virol 89:1142–1151
Bertrand L, Leiva-Torres GA, Hyjazie H, Pearson A (2010) Conserved residues in the UL24 protein of herpes simplex virus 1 are important for dispersal of the nucleolar protein nucleolin. J Virol 84:109–118
Besse S, Puvion-Dutilleul F (1996) Distribution of ribosomal genes in nucleoli of herpes simplex virus type 1 infected cells. Eur J Cell Biol 71:33–44
Boisvert FM, van Koningsbruggen S, Navascués J, Lamond AI (2007) The multifunctional nucleolus. Nat Rev Mol Cell Biol 8:574–585
Camus S, Menéndez S, Cheok CF, Stevenson LF, Laín S, Lane DP (2007) Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6. Oncogene 26:4059–4070
Castedo M, Kroemer G (2002) The beauty of death. Trends Cell Biol 12:446
Castedo M, Perfettini JL, Roumier T, Kroemer G (2002) Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe. Cell Death Differ 9:1287–1293
De Bolle L, Hatse S, Verbeken E, De Clercq E, Naesens L (2004) Human herpesvirus 6 infection arrests cord blood mononuclear cells in G(2) phase of the cell cycle. FEBS Lett 560:25–29
Direkze S, Laman H (2004) Regulation of growth signalling and cell cycle by Kaposi's sarcoma-associated herpesvirus genes. Int J Exp Pathol 85:305–319
E X, Pickering MT, Debatis M, Castillo J, Lagadinos A, Wang S, Lu S, Kowalik TF (2011) An E2F1-mediated DNA damage response contributes to the replication of human cytomegalovirus. PLoS Pathog 7:e1001342
Flemington EK (2001) Herpesvirus lytic replication and the cell cycle: arresting new developments. J Virol 75:4475–4481
Fu L, Van Doorslaer K, Chen Z, Ristriani T, Masson M, Travé G, Burk RD (2010) Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity. PLoS One 5(9):pii:e12816
Fukumori T, Akari H, Yoshida A, Fujita M, Koyama AH, Kagawa S, Adachi A (2000) Regulation of cell cycle and apoptosis by human immunodeficiency virus type 1 Vpr. Microbes Infect 2:1011–1017
Gaspar M, Shenk T (2006) Human cytomegalovirus inhibits a DNA damage response by mislocalizing checkpoint proteins. Proc Natl Acad Sci U S A 103:2821–2826
Gatza ML, Chandhasin C, Ducu RI, Marriott SJ (2005) Impact of transforming viruses on cellular mutagenesis, genome stability, and cellular transformation. Environ Mol Mutagen 45:304–325
Goodwin EC, Naeger LK, Breiding DE, Androphy EJ, DiMaio D (1998) Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines. J Virol 72:3925–3934
Hobbs WE, DeLuca NA (1999) Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0. J Virol 73:8245–8255
Hong-Yan Z, Murata T, Goshima F, Takakuwa H, Koshizuka T, Yamauchi Y, Nishiyama Y (2001) Identification and characterization of the UL24 gene product of herpes simplex virus type 2. Virus Genes 22:321–327
Iwanaga R, Ozono E, Fujisawa J, Ikeda MA, Okamura N, Huang Y, Ohtani K (2008) Activation of the cyclin D2 and cdk6 genes through NF-kappaB is critical for cell-cycle progression induced by HTLV-I Tax. Oncogene 27:5635–5642
Johnson DG, Walker CL (1999) Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 39:295–312
Kastan MB, Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432:316–323
Kawaguchi Y, Van Sant C, Roizman B (1997) Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3. J Virol 71:7328–7336
Kino T, Gragerov A, Valentin A, Tsopanomihalou M, Ilyina-Gragerova G, Erwin-Cohen R, Chrousos GP, Pavlakis GN (2005) Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: implications for cell cycle arrest. J Virol 79:2780–2787
Knight JS, Robertson ES (2004) Epstein–Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity. J Virol 78:1981–1991
Knox EG, Shannon HS (1988) Cancer of the cervix and the papilloma viruses. Eur J Epidemiol 4:83–92
Kornitzer D, Sharf R, Kleinberger T (2001) Adenovirus E4orf4 protein induces PP2A-dependent growth arrest in Saccharomyces cerevisiae and interacts with the anaphase-promoting complex/cyclosome. J Cell Biol 154:331–344
Li L, Gu B, Zhou F, Chi J, Wang F, Peng G, Xie F, Qing J, Feng D, Lu S, Yao K (2011) Human herpesvirus 6 suppresses T cell proliferation through induction of cell cycle arrest in infected cells in the G2/M phase. J Virol 85:6774–6783
Lu M, Shenk T (1999) Human cytomegalovirus UL69 protein induces cells to accumulate in G1 phase of the cell cycle. J Virol 73:676–683
Lukas J, Lukas C, Bartek J (2004) Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time. DNA Repair (Amst) 3:997–1007
Luo MH, Rosenke K, Czornak K, Fortunato EA (2007) Human cytomegalovirus disrupts both ataxia telangiectasia mutated protein (ATM)- and ATM-Rad3-related kinase-mediated DNA damage responses during lytic infection. J Virol 81:1934–1950
Luo Y, Chen AY, Qiu J (2011) Bocavirus infection induces a DNA damage response that facilitates viral DNA replication and mediates cell death. J Virol 85:133–145
Lymberopoulos MH, Bourget A, Abdeljelil NB, Pearson A (2011) Involvement of the UL24 protein in herpes simplex virus 1-induced dispersal of B23 and in nuclear egress. Virology 412:341–348
McVoy MA, Adler SP (1994) Human cytomegalovirus DNA replicates after early circularization by concatemer formation, and inversion occurs within the concatemer. J Virol 68:1040–1051
Moody CA, Laimins LA (2009) Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog 5:e1000605
Moody CA, Laimins LA (2010) Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 10:550–560
Moore PS, Chang Y (1998) Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV. Trends Genet 14:144–150
Nascimento R, Parkhouse RM (2007) Murine gammaherpesvirus 68 ORF20 induces cell-cycle arrest in G2 by inhibiting the Cdc2–cyclin B complex. J Gen Virol 88:1446–1453
Nascimento R, Dias JD, Parkhouse RM (2009) The conserved UL24 family of human alpha, beta and gamma herpesviruses induces cell cycle arrest and inactivation of the cyclinB/cdc2 complex. Arch Virol 154:1143–1149
Nishioka WK, Welsh RM (1994) Susceptibility to cytotoxic T lymphocyte-induced apoptosis is a function of the proliferative status of the target. J Exp Med 179:769–774
Øster B, Bundgaard B, Höllsberg P (2005) Human herpesvirus 6B induces cell cycle arrest concomitant with p53 phosphorylation and accumulation in T cells. J Virol 79:1961–1965
Pearson A, Coen DM (2002) Identification, localization, and regulation of expression of the UL24 protein of herpes simplex virus type 1. J Virol 76:10821–10828
Pickering MT, Kowalik TF (2006) Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation. Oncogene 25:746–755
Pietenpol JA, Stewart ZA (2002) Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology 181–182:475–481
Planelles V, Jowett JB, Li QX, Xie Y, Hahn B, Chen IS (1996) Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J Virol 70:2516–2524
Redpath S, Angulo A, Gascoigne NR, Ghazal P (2001) Immune checkpoints in viral latency. Annu Rev Microbiol 55:531–560
Sagou K, Uema M, Kawaguchi Y (2010) Nucleolin is required for efficient nuclear egress of herpes simplex virus type 1 nucleocapsids. J Virol 84:2110–2121
Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, Murakami M, Cai Q, Robertson ES (2011) Epstein–Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1. PLoS Pathog 7:e1001275
Shi Y, Dodson GE, Shaikh S, Rundell K, Tibbetts RS (2005) Ataxia-telangiectasia-mutated (ATM) is a T-antigen kinase that controls SV40 viral replication in vivo. J Biol Chem 280:40195–40200
Smits VA, Medema RH (2001) Checking out the G(2)/M transition. Biochim Biophys Acta 1519:1–12
Song B, Liu JJ, Yeh KC, Knipe DM (2000) Herpes simplex virus infection blocks events in the G1 phase of the cell cycle. Virology 267:326–334
Soutoglou E, Misteli T (2008) Activation of the cellular DNA damage response in the absence of DNA lesions. Science 320:1507–1510
Stracker TH, Carson CT, Weitzman MD (2002) Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418:348–352
Sullivan CS, Pipas JM (2002) T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis. Microbiol Mol Biol Rev 66:179–202
Sunil-Chandra NP, Efstathiou S, Nash AA (1992) Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol 73(Pt 12):3275–3279
Upton JW, van Dyk LF, Speck SH (2005) Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks. Virology 341:271–283
van Dyk LF, Hess JL, Katz JD, Jacoby M, Speck SH, Virgin HW, V I (1999) The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes. J Virol 73:5110–5122
Verschuren EW, Jones N, Evan GI (2004) The cell cycle and how it is steered by Kaposi's sarcoma-associated herpesvirus cyclin. J Gen Virol 85:1347–1361
Vossen MT, Westerhout EM, Söderberg-Nauclér C, Wiertz EJ (2002) Viral immune evasion: a masterpiece of evolution. Immunogenetics 54:527–542
Wang SK, Duh CY, Chang TT (2000) Cloning and identification of regulatory gene UL76 of human cytomegalovirus. J Gen Virol 81:2407–2416
Wang SK, Duh CY, Wu CW (2004) Human cytomegalovirus UL76 encodes a novel virion-associated protein that is able to inhibit viral replication. J Virol 78:9750–9762
Wang Y, Xu Y, Tong W, Pan T, Li J, Sun S, Shao J, Ding H, Toyoda T, Yuan Z (2011) Hepatitis C virus NS5B protein delays S phase progression in human hepatocyte-derived cells by relocalizing cyclin-dependent kinase 2-interacting protein (CINP). J Biol Chem 286:26603–26615
Weitzman MD, Carson CT, Schwartz RA, Lilley CE (2004) Interactions of viruses with the cellular DNA repair machinery. DNA Repair (Amst) 3:1165–1173
Wiebusch L, Hagemeier C (1999) Human cytomegalovirus 86-kilodalton IE2 protein blocks cell cycle progression in G(1). J Virol 73:9274–9283
Yu J, Zhang L (2005) The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 331:851–858
Acknowledgment
The authors thank the “Fundação para a Ciencia e a Tecnologia”, SFRH/BPD/34643/2007 (Nascimento R.), SFRH/BD/27677/2006 (Costa H.).
Author information
Authors and Affiliations
Corresponding author
Additional information
Handling Editor: David Robinson
Rights and permissions
About this article
Cite this article
Nascimento, R., Costa, H. & Parkhouse, R.M.E. Virus manipulation of cell cycle. Protoplasma 249, 519–528 (2012). https://doi.org/10.1007/s00709-011-0327-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00709-011-0327-9